In Vivo Imaging Reagents


Our comprehensive suite of fluorescent and bioluminescent in vivo imaging reagents enables unmatched imaging of a broad-range of disease-related biomarkers and pathways for your research. Our optical reagents, labeling kits and dyes have been optimized on our IVIS® in vivo imaging platform. In addition to our in vivo optical imaging reagents, we offer radioimaging nuclides for PET imaging studies.

  • Fluorescent agents, Dyes, Labeling Kits, and Nanoparticles, and Fluorescent Imaging Application Panels
  • Bioluminescent oncology cell lines created using luciferase (Red-FLuc) vector for ultra bright sensitivity
  • Bioluminescent bacterial cell lines
  • Bioluminescent substrates including D-Luciferin K+ salt and RediJect Luciferin in ready-to-use injectable format
  • Radioimaging reagents

Download our interactive In Vivo Solutions eBook to learn more

For research use only. Not for use in diagnostic procedures.

Products & Services (109)

Filters :

Therapeutic Area
  • Angiogenesis (9)
  • Arthritis (18)
  • Atherosclerosis (13)
  • Bacterial infection (18)
  • Inflammation (18)
  • Oncology/Cancer (23)
  • Toxicology (1)
  • Tumor Metabolism (1)
  • Vascular disease (5)
Product Brand Name
  • BacteriSense (1)
  • Bioware Brite (20)
  • BombesinRSense (1)
  • Cat B FAST (2)
  • Cat K FAST (1)
  • FolateRSense (1)
  • GastroSense (1)
  • Genhance (4)
  • GFR-Vivo (1)
  • HypoxiSense (1)
  • IntegriSense (3)
  • MMPSense (1)
  • OsteoSense (3)
  • ProSense (1)
  • RediFect (3)
  • ReninSense (1)
  • Superhance (1)
  • TLectinSense (1)
  • Transferrin-Vivo (1)
  • VivoTag (17)
  • VivoTrack (2)
  • XenoLight (25)
Fluorescent Agent Type
  • Activatable (7)
  • Cell labeling (2)
  • Labeling (15)
  • Targeted (20)
  • Vascular (9)
Experimental Type
  • In vivo (1)
Imaging Modality
  • Bioluminenscence (41)
  • Bioluminescence (1)
  • Chemilumiluminescence (2)
  • Fluorescence (65)
Oncology Cell Line
  • Colorectal (3)
  • Breast (3)
  • Lung (3)
  • Prostate (3)
  • Ovarian (1)
  • Liver (1)
  • Fibrosarcoma (1)
  • Melanoma (1)
  • Pancreatic (1)
  • Blood (1)
  • Brain (2)

1-12 of 109 Products & Services

Sort by

  • Jump to:
Business Insights (5)

1-5 of 5 Business Insights

Sort by

  • Application Note

    Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

    Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection. This application note investigates the use of three fluorescent imaging probes, to detect and monitor vascular leak and inflammation in preclinical mouse breast cancer models.

  • Application Note

    NIR Fluorescent Cell Labeling for In Vivo Cell Tracking (VivoTrack 680)

    Fluorescent dyes have been used for many years to label cells for microscopy studies, and a variety of dyes in the visible fluorescence spectrum are available to label different cellular compartments and organelles. Efficient delivery of the fluorophore to the cell without excessively modifying surface proteins or perturbing cell function is the major biotechnological challenge. In addition, researchers have taken on the challenge of in vivo imaging, focusing on near infrared (NIR) dyes that fluoresce in a spectral region better suited for in vivo imaging due to reduced background and higher tissue penetration.

  • Application Note

    Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

    Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting the importance of early integration of liver safety assessment in the drug development process. A technical approach for in vivo toxicology determination was developed using Acetaminophen (APAP), a commonly used over-the-counter analgesic and antipyretic drug, to induce acute hepatocellular liver injury.

  • Application Note

    Multiplex 2D Imaging of NIR Molecular Imaging Agents on the IVIS SpectrumCT and FMT 4000

    Epifluorescence (2D) imaging of superficially implanted mouse tumor xenograft models offers a fast and simple method for assessing tumor progression or response to therapy. This approach for tumor assessment requires the use of near infrared (NIR) imaging agents specific for different aspects of tumor biology, and this Application Note highlights the ease and utility of multiplex NIR fluorescence imaging to characterize the complex biology within tumors growing in a living mouse.

  • Poster

    Combined efficacy & toxicity imaging following acute 5-FU treatment of HT-29 tumor xenografts

    Cancer chemotherapy can produce severe side effects such as suppression of immune function and damage to heart muscle, gastrointestinal tract, and liver. If serious enough, tissue injury can be a major reason for late stage termination of drug discovery research projects, so it is becoming more important to integrate safety/toxicology assessments earlier in the drug development process. There are a variety of traditional serum markers, tailored mechanistically to specific tissues, however there are no current non-invasive assessment tools that are capable of looking broadly at in situ biological changes in target and non-target tissue induced by chemical insult.